RxDoctor Payments DataLook up a doctor →

Peter Kabos, MD

Medical Oncology · Aurora, CONPI 1508912270

Payments from drug & device makers

$3,510,362in general payments, 2019–2025

Across 346 payments — averaging $10,146 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1.1M
  • Genentech, Inc.$793K
  • Pfizer$532K
  • Sanofi US Services Inc.$406K
  • Eli Lilly$252K
  • Merck$249K
  • plus $199K from 9 others
$39,849in research payments, 2019–2025

Across 26 payments — averaging $1532.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$23K
  • AbbVie$12K
  • Sanofi$4K
  • Pfizer$1K

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca53$1,079,809
Genentech, Inc.116$793,499
Pfizer67$532,011
Sanofi US Services Inc.50$405,551
Eli Lilly12$252,277
Merck3$248,500
Radius Health, Inc.24$107,933
Jazz Pharmaceuticals Inc.10$73,010
AbbVie4$8,700
Stemline Therapeutics Inc.1$4,608
Novartis1$2,656
Lilly USA, LLC1$1,600
Genentech USA, Inc.1$123
Gilead2$73
Daiichi Sankyo Inc.1$13

How this compares

$3,510,362 in reported general payments places this provider in the 85th percentile of 96 medical oncology providers in Colorado.

See all medical oncology providers in Colorado

Medicare billing

Part B allowed, 2024
$37,022
Medicare patients
96
Services billed
283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →